UMIN-CTR Clinical Trial

Basic information
Public title	Effect of intake of rice crackers prepared from high resistant starch rice (A-12) on increase in blood glucose levels.
Acronym	Effect of intake of rice crackers prepared from high resistant starch rice (A-12) on increase in blood glucose levels.
Scientific Title	Effect of intake of rice crackers prepared from high resistant starch rice (A-12) on increase in blood glucose levels.
Scientific Title:Acronym	Effect of intake of rice crackers prepared from high resistant starch rice (A-12) on increase in blood glucose levels.
Region	Japan

Condition
Condition	Healthy human
Classification by specialty	Adult
Classification by malignancy	Others
Genomic information	NO

Objectives
Narrative objectives1	Evaluation of changes in postprandial blood glucose levels and insulin levels after intake of test and control foods, along with their incremental area under the curves of blood glucose levels (IAUCg) and insulin levels (IAUCi).
Basic objectives2	Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes	blood glucose levels, IAUCg
Key secondary outcomes	insulin levels, IAUCi

Base
Study type	Interventional

Study design
Basic design	Cross-over
Randomization	Randomized
Randomization unit	Individual
Blinding	Single blind -investigator(s) and assessor(s) are blinded
Control	Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms	2
Purpose of intervention	Prevention
Type of intervention	Food
Interventions/Control_1	Intake of test food (53.5 g ) and water (310 ml). > washout > intake of control food (50.4 g) and water (310 ml).
Interventions/Control_2	Intake of control food (50.4 g ) and water (310 ml). > washout > intake of test food (53.5 g) and water (310 ml).
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit	20 years-old <=
Age-upper limit	65 years-old >
Gender	Male and Female
Key inclusion criteria	1. Fasting plasma glucose <126mg/dL. 2.Individual having screening test result and questionnaire result judged to be appropriate for this study by investigator.
Key exclusion criteria	1. Diabetes mellitus under medical treatment. 2. Individual having severe diseases (e.g. Cerebrovascular, heart, kidney, gastrointestinal diseases. ) 3. Individual received gastrectomy, enterectomy, and gastro-intestinal diseases, judged to be inappropriate for this study. 4. Pregnant, women having the possibility, and lactating women. 5. Participants in order clinical trial. 6. Individual rejected participating in this study by chief investigator.
Target sample size	16

Research contact person
Name of lead principal investigator	1st name Kenichi Middle name Last name Watanabe
Organization	Niigata Bio-Research Park, Inc
Division name	Advisor
Zip code	956-0841
Address	316-2, Higashijima, Akiha-ku, Niigata, 956-0841, Japan
TEL	0250-25-1196
Email	wataken@med.niigata-u.ac.jp

Public contact
Name of contact person	1st name Hiroshi Middle name Last name Goto
Organization	Niigata Bio-Research Park, Inc
Division name	Business promotion division
Zip code	956-0841
Address	316-2 Higashijima, Akiha-ku, Niigata, 956-0841, Japan
TEL	0250-25-1196
Homepage URL
Email	goto@nbrp.co.jp

Sponsor
Institute	Niigata Bio-Research Park, Inc
Institute
Department

Funding Source
Organization	Akita Prefectural University
Organization
Division
Category of Funding Organization	Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization	NBRC Research Ethics Review Committee
Address	316-2, Higashijima, Akiha-ku, Niigata, 956-0841, Japan
Tel	0250-25-1196
Email	nbrp-food-navi@nbrp.co.jp

Secondary IDs
Secondary IDs	NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information	2021 Year 11 Month 28 Day

Related information
URL releasing protocol
Publication of results	Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status	Completed
Date of protocol fixation	2021 Year 10 Month 15 Day
Date of IRB	2021 Year 11 Month 01 Day
Anticipated trial start date	2021 Year 11 Month 28 Day
Last follow-up date	2022 Year 02 Month 12 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date	2021 Year 11 Month 25 Day
Last modified on	2022 Year 03 Month 02 Day

Link to view the page
URL(English)	https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000052687